𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Letrozole (femara) is a more effective inhibitor of estrogen activity than tamoxifen: Evidence from a randomized phase III trial of 4 months preoperative endocrine therapy for postmenopausal women with primary invasive breast cancer

✍ Scribed by M.J. Ellis; B. Sing; W.R. Miller; A. Llombart-Cussac; F. Janicke; D.B. Evans; M. Borgs; E. Quebe-Fehling; C. Brady; M. Dugan; A. Coop


Book ID
117657600
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
135 KB
Volume
37
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.